Headlines & Global News |
FDA Reviewers Recommend Against Approval For Novartis Heart Failure Drug
Forbes On Thursday the FDA’s Cardiovascular and Renal Drugs Advisory Committee will discuss the biologics license application (BLA) for serelaxin injection (proposed trade name Reasanz) from Novartis. The indication is for the improvement of the symptoms of … FDA staff review recommends against Novartis heart failure drugReuters India |
Vegetable heart mosaic in India sets Guinness record – FreshPlaza
|
Vegetable heart mosaic in India sets Guinness record
FreshPlaza A+ | A-. Vegetable heart mosaic in India sets Guinness record. A heart-shaped mosaic measuring nearly 5,166 square feet has entered the Guinness World Records as the world’s largest vegetable heart mosaic, organisers of a health event said here Friday. |
Obinutuzumab Gains Role in CLL Guidelines – OncLive
OncLiveObinutuzumab Gains Role in CLL GuidelinesOncLiveThe first-in-class glycoengineered type-2 antibody has demonstrated superior outcomes in combination with chlorambucil to both a rituximab (Rituxan) plus chlorambucil regimen and to chlorambucil al…
The sad story of Jahi McMath – Calaveras Enterprise
|
The sad story of Jahi McMath
Calaveras Enterprise Jahai was a 13-year-old girl who went into Children’s Hospital in Oakland for a routine tonsil surgery, and while in recovery, she bled profusely, resulting in a massive loss of oxygen to her brain that ultimately caused brain death. The hospital … |
FDA staff review recommends against Novartis heart failure drug – Reuters
News Tonight Africa |
FDA staff review recommends against Novartis heart failure drug
Reuters “We recommend that serelaxin not be approved at this time because there is insufficient evidence to support the proposed indication to “improve the symptoms of acute heart failure through reduction of the rate of worsening of heart failure,” the report … FDA Reviewers Recommend Against Approval For Novartis Heart Failure DrugForbes FDA Rejects Approval of Novartis drug Serelaxin for Heart FailureNews Tonight Africa FDA Staff Recommends Against Approval For Novartis’ Heart-failure Drug …NASDAQ FierceBiotech all 28 news articles » |
DESJARDINS — Sometimes right is wrong, and vice versa 0 – Belleville Intelligencer
DESJARDINS — Sometimes right is wrong, and vice versa 0Belleville IntelligencerThe show demonstrates the need for a debate on the question of when life ends where both brain death and cardiac death are considered, where a greater degree of confidence …
Coroner: Bucks inmate died of heart failure during heroin withdrawal – Bucks County Courier Times
|
Coroner: Bucks inmate died of heart failure during heroin withdrawal
Bucks County Courier Times A 49-year-old Bensalem woman found dead inside her Bucks County prison cell suffered sudden cardiac death during heroin detoxification, according to the Bucks County coroner. Marlene Yarnall was found dead in her cell in the “F” module of the prison … |
One man's quest to train India's many quack doctors – GlobalPost
|
One man’s quest to train India’s many quack doctors
GlobalPost The controversial effort targets legions of untrained healthcare providers who prescribe sketchy liver tonics and antibiotic cocktails. PHOOLBERIA, India — Squatting on their haunches among fruit trees and orange marigolds, barefoot villagers wait in … |
Afinitor/Aromasin combo disappoints in breast cancer trial – PharmaTimes
Afinitor/Aromasin combo disappoints in breast cancer trialPharmaTimesEagerly-awaited results from the BOLERO-2 trial looking at the mTOR inhibitor Afinitor (everolimus) plus the aromatase inhibitor Aromasin (exemestane) were presented at the European B…
Cayuga County Health Dept.: Why you should become an organ donor – Auburn Citizen
|
Cayuga County Health Dept.: Why you should become an organ donor
Auburn Citizen If you have questions about why you should become an organ donor, what the process of becoming an organ donor involves, and how to become an organ donor, hopefully you’ll find this article helpful. Why should you consider becoming an organ donor? The … |